These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26996746)

  • 1. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
    Zhang L; Keung W; Samokhvalov V; Wang W; Lopaschuk GD
    Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
    Arumugam S; Sreedhar R; Thandavarayan RA; Karuppagounder V; Watanabe K
    Drug Discov Today; 2016 Jun; 21(6):1003-8. PubMed ID: 26905600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
    Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders.
    Lopaschuk GD
    Ann Nutr Metab; 2016; 68 Suppl 3():15-20. PubMed ID: 27931032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation.
    Abo Alrob O; Lopaschuk GD
    Biochem Soc Trans; 2014 Aug; 42(4):1043-51. PubMed ID: 25110000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.
    Dolinsky VW; Cole LK; Sparagna GC; Hatch GM
    Biochim Biophys Acta; 2016 Oct; 1861(10):1544-54. PubMed ID: 26972373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuel availability and fate in cardiac metabolism: A tale of two substrates.
    Pascual F; Coleman RA
    Biochim Biophys Acta; 2016 Oct; 1861(10):1425-33. PubMed ID: 26993579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered myocardial metabolic adaptation to increased fatty acid availability in cardiomyocyte-specific CLOCK mutant mice.
    Peliciari-Garcia RA; Goel M; Aristorenas JA; Shah K; He L; Yang Q; Shalev A; Bailey SM; Prabhu SD; Chatham JC; Gamble KL; Young ME
    Biochim Biophys Acta; 2016 Oct; 1861(10):1579-95. PubMed ID: 26721420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipotoxicity in obesity and diabetes-related cardiac dysfunction.
    Zlobine I; Gopal K; Ussher JR
    Biochim Biophys Acta; 2016 Oct; 1861(10):1555-68. PubMed ID: 26899197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD36 in the regulation of myocardial lipid metabolism.
    Kim TT; Dyck JR
    Biochim Biophys Acta; 2016 Oct; 1861(10):1450-60. PubMed ID: 26995462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.
    Luiken JJ
    Appl Physiol Nutr Metab; 2009 Jun; 34(3):473-80. PubMed ID: 19448717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N; Mori J; Lopaschuk GD
    Br J Pharmacol; 2014 Apr; 171(8):2080-90. PubMed ID: 24147975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fatty acid metabolism in health and disease.
    Lopaschuk GD; Ussher JR; Folmes CD; Jaswal JS; Stanley WC
    Physiol Rev; 2010 Jan; 90(1):207-58. PubMed ID: 20086077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.
    Yan J; Young ME; Cui L; Lopaschuk GD; Liao R; Tian R
    Circulation; 2009 Jun; 119(21):2818-28. PubMed ID: 19451348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.